6159-56-4
Chemical Structure
(±)-Vasicine
Synonym(s): (±)-Peganine
- CAS No.: 6159-56-4
- Formula:C11H12N2O
- Molecular Weight:188.23
IUPAC Name: 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-3-ol
InChIKey: YIICVSCAKJMMDJ-UHFFFAOYSA-N
SMILES: OC1CCN2C1=NC3=C(C=CC=C3)C2
Biological Activity: (±)-Vasicine is the racemate of Vasicine. Vasicine (Peganine) significantly inhibits H+-K+-ATPase activity in vitro with an IC50 of 73.47 μg/mL. Anti-ulcer activity. Vasicine shows significant anti-secretory, antioxidant and cytoprotective effect[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(±)-Vasicine | 99.85% | (±)-Vasicine is the racemate of Vasicine. Vasicine (Peganine) significantly inhibits H+-K+-ATPase activity in vitro with an IC50 of 73.47 μg/mL. Anti-ulcer activity. Vasicine shows significant anti-secretory, antioxidant and cytoprotective effect. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Vasicine (Standard) | ≥98% | (±)-Vasicine (Standard) is the analytical standard of (±)-Vasicine (HY-N7031). This product is intended for research and analytical applications. (±)-Vasicine is the racemate of Vasicine. Vasicine (Peganine) significantly inhibits H+-K+-ATPase activity in vitro with an IC50 of 73.47 μg/mL. Anti-ulcer activity. Vasicine shows significant anti-secretory, antioxidant and cytoprotective effect. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-N1103Vasicine -
Similarity Score 0.98
HY-N1103ARVasicine hydrochloride (Standard) -
Similarity Score 0.82
HY-N1102Vasicinol -
Similarity Score 0.76
HY-108048ADesoxypeganine hydrochloride -
Similarity Score 0.76
HY-108048Desoxypeganine -
Similarity Score 0.57
HY-W016644(S)-1-Benzylpyrrolidin-3-ol -
Similarity Score 0.56
HY-B1624Debrisoquin -
Similarity Score 0.56
HY-B1624CDebrisoquin hydrobromide -
Similarity Score 0.56
HY-W195509Debrisoquin hydroiodide -
Explore the MedChemAI to find more analogs